LigaChem Biosciences Statistics

Total Valuation

LigaChem Biosciences has a market cap or net worth of KRW 3.41 trillion. The enterprise value is 2.89 trillion.

Market Cap	3.41T
Enterprise Value	2.89T

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

LigaChem Biosciences has 36.47 million shares outstanding. The number of shares has increased by 14.62% in one year.

Current Share Class	n/a
Shares Outstanding	36.47M
Shares Change (YoY)	+14.62%
Shares Change (QoQ)	+14.16%
Owned by Insiders (%)	4.21%
Owned by Institutions (%)	13.45%
Float	25.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	113.73
PS Ratio	31.30
PB Ratio	5.34
P/TBV Ratio	5.41
P/FCF Ratio	76.52
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-986.46
EV / Sales	28.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	64.91

Financial Position

The company has a current ratio of 6.81, with a Debt / Equity ratio of 0.02.

Current Ratio	6.81
Quick Ratio	6.73
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	0.28
Interest Coverage	-55.81

Financial Efficiency

Return on equity (ROE) is -0.73% and return on invested capital (ROIC) is -4.91%.

Return on Equity (ROE)	-0.73%
Return on Assets (ROA)	-4.37%
Return on Capital (ROIC)	-4.91%
Revenue Per Employee	622.19M
Profits Per Employee	-17.99M
Employee Count	163
Asset Turnover	0.22
Inventory Turnover	85.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +100.64% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+100.64%
50-Day Moving Average	114,862.00
200-Day Moving Average	87,032.50
Relative Strength Index (RSI)	37.00
Average Volume (20 Days)	703,535

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LigaChem Biosciences had revenue of KRW 101.42 billion and -2.93 billion in losses. Loss per share was -86.38.

Revenue	101.42B
Gross Profit	85.58B
Operating Income	-32.40B
Pretax Income	-4.38B
Net Income	-2.93B
EBITDA	-27.46B
EBIT	-32.40B
Loss Per Share	-86.38

Full Income Statement

Balance Sheet

The company has 529.91 billion in cash and 12.67 billion in debt, giving a net cash position of 517.24 billion or 14,182.39 per share.

Cash & Cash Equivalents	529.91B
Total Debt	12.67B
Net Cash	517.24B
Net Cash Per Share	14,182.39
Equity (Book Value)	637.31B
Book Value Per Share	17,495.34
Working Capital	479.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 46.72 billion and capital expenditures -2.15 billion, giving a free cash flow of 44.56 billion.

Operating Cash Flow	46.72B
Capital Expenditures	-2.15B
Free Cash Flow	44.56B
FCF Per Share	1,221.89

Full Cash Flow Statement

Margins

Gross margin is 84.38%, with operating and profit margins of -31.95% and -2.89%.

Gross Margin	84.38%
Operating Margin	-31.95%
Pretax Margin	-4.32%
Profit Margin	-2.89%
EBITDA Margin	-27.07%
EBIT Margin	-31.95%
FCF Margin	43.94%

Dividends & Yields

LigaChem Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.62%
Shareholder Yield	-14.62%
Earnings Yield	-0.09%
FCF Yield	1.31%

Stock Splits

The last stock split was on June 16, 2020. It was a forward split with a ratio of 2.

Last Split Date	Jun 16, 2020
Split Type	Forward
Split Ratio	2

Scores

LigaChem Biosciences has an Altman Z-Score of 14.79.

Altman Z-Score	14.79
Piotroski F-Score	n/a